Weigao Group Medical Polymer repurchases shares on HKEX

Shandong Weigao Group Medical Polymer (HKEX: 1066) disclosed a share repurchase of 60,400 ordinary shares on June 6, 2025, conducted on the Hong Kong Stock Exchange. The shares were bought back at prices ranging from HKD 5.69 to HKD 5.72 per share, with an aggregate price paid of HKD 345,476. Following the repurchase, the number of issued shares excluding treasury shares stands at 4,514,915,924, while the number of treasury shares increased to 7,416,400. The repurchase falls under an existing mandate approved on May 27, 2025, authorizing the company to repurchase up to 451,560,392 shares. The company confirmed that the repurchases comply with the Main Board Rules and that there have been no material changes to the particulars contained in the Explanatory Statement dated April 30, 2025. The moratorium period for any new issue of shares or sale/transfer of treasury shares is up to July 6, 2025.